How many years of comparable data are there for Argentina and Kazakhstan?

7 years are reported by both, from 2008 to 2021.

Where does this data come from?

Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Argentina vs Kazakhstan: Tuberculosis patients living with HIV receiving antiretroviral therapy

Argentina

623 patients

in 2021

Kazakhstan

581 patients

in 2021

Argentina rank

44th

Kazakhstan rank

46th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

Argentina
Kazakhstan

How they compare

Argentina currently reports 623 patients against 581 patients in Kazakhstan, a difference of 42 patients.

That makes Argentina's figure about 1.1 times Kazakhstan's.

The two have swapped places 2 times across 7 shared years of data; in 2008 it was Argentina ahead.

Argentina ranks 44th and Kazakhstan ranks 46th of 183 countries.

Across the 3 decades both report, Argentina averaged higher in 1 and Kazakhstan in 2.

Head to head by decade

Decade	Argentina	Kazakhstan	Difference	Ahead
2000s	315 patients	29 patients	286 patients	Argentina
2010s	122.5 patients	555.25 patients	432.75 patients	Kazakhstan
2020s	545 patients	586.5 patients	41.5 patients	Kazakhstan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Argentina or Kazakhstan?: Argentina, at 623 patients against 581 patients in Kazakhstan as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Argentina and Kazakhstan?: 42 patients, with Argentina ahead.
How many years of comparable data are there for Argentina and Kazakhstan?: 7 years are reported by both, from 2008 to 2021.
How do Argentina and Kazakhstan rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?: Argentina ranks 44th and Kazakhstan ranks 46th of 183 countries.
Where does this data come from?: Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Argentina vs Kazakhstan: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 13 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/argentina/kazakhstan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/argentina/kazakhstan/">Argentina vs Kazakhstan: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator: Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit: patients
Source: Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 183 places, 2,780 data points, 2000–2021
Last refreshed: 28 August 2026

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.